[en] Purpose: We evaluated the rate of significant colonic and extra-colonic abnormalities at computed tomography colonography (CTC), accordingto symptoms and age.
Materials and methods: We retrospectively evaluated 7361 consecutive average-risk subjects (3073 males, average age: 60.3 ± 13.9; range 18–96years) for colorectal cancer (CRC) who underwent CTC. They were divided into three groups according to clinical symptoms: 1343 asymptomaticindividuals (group A), 899 patients with at least one “alarm” symptom for CRC, including rectal bleeding and unexplained weight loss (groupC), and 5119 subjects with other gastrointestinal symptoms (group B). Diagnostic and test-positive rates of CTC were established using opticalcolonoscopy (OC) and/or surgery as reference standard. In addition, clinically significant extra-colonic findings were noted.
Results: 903 out of 7361 (12%, 95% confidence interval (CI) 0.11–0.13) subjects had at least one clinically significant colonic finding at CTC. CTCtrue positive fraction and false positive fraction were respectively 637/642 (99.2%, 95%CI 0.98–0.99) and 55/692 (7.95%, 95%CI 0.05–0.09). Thepooled test-positive rate in group C (138/689, 20.0%, 95%CI 0.17–0.23) was significantly higher than in both groups A (79/1343, 5.9%, 95%CI0.04–0.07) and B (420/5329, 7.5%, 95%CI 0.07–0.08) (p < 0.001). Aging and male gender were associated to a higher test positive rate. The rateof clinically significant extra-colonic findings was significantly higher in group C (44/689, 6.4%, 95%CI 0.04–0.08) versus groups A (26/1343,1.9%, 95%CI 0.01–0.02) and B (64/5329, 1.2%, 95%CI 0.01–0.02) (p < 0.001).Conclusion: Both test-positive and significant extra-colonic finding rates at CTC are significantly increased in the presence of “alarm” gastroin-testinal symptoms especially in older patients.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Hock, Danielle
MATERNE, Roland
Ouhadi, Roxanne
Mancini, Isabelle
Aouachria, Samy
NCHIMI LONGANG, Alain ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiodiagnostic
Language :
English
Title :
Test-positive rate at CT colonography is increased by rectal bleeding and/orunexplained weight loss, unlike other common gastrointestinal symptoms
Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013, 49(6):1374-1403.
Levin B., Lieberman D.A., McFarland B., Smith R.A., Brooks D., Andrews K.S., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008, 58(3):130-160.
McFarland E.G., Levin B., Lieberman D.A., Pickhardt P.J., Johnson C.D., Glick S.N., et al. Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology 2008, 248(3):717-720.
Arditi C., Peytremann-Bridevaux I., Burnand B., Eckardt V.F., Bytzer P., Agreus L., et al. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer. Endoscopy 2009, 41(3):200-208.
Adelstein B.A., Macaskill P., Chan S.F., Katelaris P.H., Irwig L. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterol 2011, 11:65.
Jellema P., van der Windt D.A., Bruinvels D.J., Mallen C.D., van Weyenberg S.J., Mulder C.J., et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ 2010, 340:c1269.
Lieberman D.A., Williams J.L., Holub J.L., Morris C.D., Logan J.R., Eisen G.M., et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc 2014, 80(1):133-143.
Astin M., Griffin T., Neal R.D., Rose P., Hamilton W. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract 2011, 61(586):e231-e243.
Rex D.K., Lieberman D.A. Feasibility of colonoscopy screening: discussion of issues and recommendations regarding implementation. Gastrointest Endosc 2001, 54(5):662-667.
Hoffman R.M., Espey D., Rhyne R.L. A public-health perspective on screening colonoscopy. Expert Rev Anticancer Ther 2011, 11(4):561-569.
Levin T.R. Colonoscopy capacity: can we build it? Will they come?. Gastroenterology 2004, 127(6):1841-1844.
Shapiro J.A., Seeff L.C., Thompson T.D., Nadel M.R., Klabunde C.N., Vernon S.W. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008, 17(7):1623-1630.
Halligan S., Wooldrage K., Dadswell E., Kralj-Hans I., von Wagner C., Edwards R., et al. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet 2013, 381(9873):1185-1193.
Atkin W., Dadswell E., Wooldrage K., Kralj-Hans I., von Wagner C., Edwards R., et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet 2013, 381(9873):1194-1202.
Pickhardt P.J., Choi J.R., Hwang I., Butler J.A., Puckett M.L., Hildebrandt H.A., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003, 349(23):2191-2200.
Johnson C.D., MacCarty R.L., Welch T.J., Wilson L.A., Harmsen W.S., Ilstrup D.M., et al. Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. Clin Gastroenterol Hepatol 2004, 2(4):314-321.
Sosna J., Bar-Ziv J., Libson E., Eligulashvili M., Blachar A. Critical analysis of the performance of double-contrast barium enema for detecting colorectal polyps ≥6mm in the era of CT colonography. AJR Am J Roentgenol 2008, 190(2):374-385.
Summaries for patients Screening for colorectal cancer: recommendations from the United States Preventive Services Task Force. Ann Intern Med 2002, 137(2):I38.
Hock D., Ouhadi R., Materne R., Aouchria A.S., Mancini I., Broussaud T., et al. Virtual dissection CT colonography: evaluation of learning curves and reading times with and without computer-aided detection. Radiology 2008, 248(3):860-868.
Zalis M.E., Barish M.A., Choi J.R., Dachman A.H., Fenlon H.M., Ferrucci J.T., et al. CT colonography reporting and data system: a consensus proposal. Radiology 2005, 236(1):3-9.
de Vries A.H., Bipat S., Dekker E., Liedenbaum M.H., Florie J., Fockens P., et al. Polyp measurement based on CT colonography and colonoscopy: variability and systematic differences. Eur Radiol 2010, 20(6):1404-1413.
Brown M.L., Klabunde C.N., Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med 2003, 115(2):129-133.
Seeff L.C., Manninen D.L., Dong F.B., Chattopadhyay S.K., Nadel M.R., Tangka F.K., et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?. Gastroenterology 2004, 127(6):1661-1669.
Meleine M., Matricon J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol 2014, 20(22):6725-6743.
Khan S., Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol 2010, 7(10):565-581.
Spiegel B.M., Farid M., Esrailian E., Talley J., Chang L. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010, 105(4):848-858.
Talley N.J., Boyce P., Owen B.K. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol 1995, 90(12):2115-2119.
Lieberman D.A., Holub J., Eisen G., Kraemer D., Morris C.D. Prevalence of polyps greater than 9mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol 2005, 3(8):798-805.
Cash B.D., Schoenfeld P., Chey W.D. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002, 97(11):2812-2819.
Johnson C.D., Chen M.H., Toledano A.Y., Heiken J.P., Dachman A., Kuo M.D., et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008, 359(12):1207-1217.
Pickhardt P.J., Taylor A.J., Kim D.H., Reichelderfer M., Gopal D.V., Pfau P.R. Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology 2006, 241(2):417-425.
Berrington de Gonzalez A., Kim K.P., Knudsen A.B., Lansdorp-Vogelaar I., Rutter C.M., Smith-Bindman R., et al. Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR Am J Roentgenol 2011, 196(4):816-823.